Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 16;27(4):463-471.
doi: 10.1016/j.chembiol.2020.03.015.

Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit

Affiliations
Review

Progress in Understanding Ferroptosis and Challenges in Its Targeting for Therapeutic Benefit

Yilong Zou et al. Cell Chem Biol. .

Abstract

Ferroptosis is an iron-dependent cell-death modality driven by oxidative phospholipid damage. In contrast to apoptosis, which enables organisms to eliminate targeted cells purposefully at specific times, ferroptosis appears to be a vulnerability of cells that otherwise use high levels of polyunsaturated lipids to their advantage. Cells in this high polyunsaturated lipid state generally have safeguards that mitigate ferroptotic risk. Since its recognition, ferroptosis has been implicated in degenerative diseases in tissues including kidney and brain, and is a targetable vulnerability in multiple cancers-each likely characterized by the high polyunsaturated lipid state with insufficient or overwhelmed ferroptotic safeguards. In this Perspective, we present progress toward defining the essential roles and key mediators of lipid peroxidation and ferroptosis in disease contexts. Moreover, we discuss gaps in our understanding of ferroptosis and list key challenges that have thus far limited the full potential of targeting ferroptosis for improving human health.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests S.L.S. serves on the Board of Directors of the Genomics Institute of the Novartis Research Foundation (“GNF”); is a shareholder and serves on the Board of Directors of Jnana Therapeutics; is a shareholder of Forma Therapeutics; is a shareholder and advises Kojin Therapeutics, Kisbee Therapeutics, Decibel Therapeutics, and Eikonizo Therapeutics; serves on the Scientific Advisory Boards of Eisai Co., Ltd., Ono Pharma Foundation, Exo Therapeutics, and F-Prime Capital Partners; and is a Novartis Faculty Scholar. Kojin Therapeutics in particular explores the medical potential of cell plasticity related to ferroptosis. Y.Z. declares no conflict of interest related to this work.

Figures

Figure 1.
Figure 1.. Chemical basis of lipid peroxidation and ferroptosis.
Abbreviations: GPX4, glutathione peroxidase 4; L-H, symbol for polyunsaturated lipids; Vit. E, vitamin E; Lip-1, liproxstatin-1; Fer-1, ferrostatin-1; IKE, imidazole ketone erastin; DFO, deferoxamine; BSO, L-Buthionine-(S,R)-Sulfoximine; GSH, reduced glutathione.
Figure 2.
Figure 2.. Mechanisms mediating ferroptosis sensitivity and resistance in cells.
Red: genes, metabolites, and methods that increase cellular sensitivity to ferroptosis. Green, genes, metabolites, and methods that decrease cellular sensitivity to ferroptosis. Abbreviations: PUFA, polyunsaturated fatty acids; MUFA, monounsaturated fatty acids; PROM2, Prominin2; AIFM2/FSP1, apoptosis inducing factor, mitochondrion-associated, 2 (recently renamed as ferroptosis suppressor protein 1); HILPDA, hypoxia-induced, lipid droplet associated protein; HIF-2ɑ, hypoxia-inducible factor 2ɑ; ACSL4, acyl-CoA synthetase, long-chain family member 4; LPCAT3, lysophosphatidylcholine acyltransferase 3; ESCRT, endosomal sorting complexes required for transport machinery; iNOS, inducible nitric oxide synthase.

References

    1. Achitei D, Ciobica A, Balan G, Gologan E, Stanciu C, and Stefanescu G (2013). Different profile of peripheral antioxidant enzymes and lipid peroxidation in active and non-active inflammatory bowel disease patients. Dig. Dis. Sci 58, 1244–1249. - PubMed
    1. Alim I, Caulfield JT, Chen Y, Swarup V, Geschwind DH, Ivanova E, Seravalli J, Ai Y, Sansing LH, Ste Marie EJ, et al. (2019). Selenium Drives a Transcriptional Adaptive Program to Block Ferroptosis and Treat Stroke. Cell 177, 1262–1279.e25. - PubMed
    1. Alvarez SW, Sviderskiy VO, Terzi EM, Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K, and Possemato R (2017). NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551, 639–643. - PMC - PubMed
    1. Amaral EP, Costa DL, Namasivayam S, Riteau N, Kamenyeva O, Mittereder L, Mayer-Barber KD, Andrade BB, and Sher A (2019). A major role for ferroptosis in Mycobacterium tuberculosis-induced cell death and tissue necrosis. J. Exp. Med 216, 556–570. - PMC - PubMed
    1. Badgley MA, Kremer D, Carlo Maurer H, DelGiorno KE, Lee H-J, Purohit V, Sagalovskiy I, Ma A, Kapillian J, Firl CEM, et al. (2019). “Induction of pancreatic tumor-selective ferroptosis through modulation of cystine import.”

Publication types

MeSH terms

Substances

LinkOut - more resources